Lipidomic profiling reveals early-stage metabolic dysfunction in overweight or obese humans

被引:32
|
作者
Mousa, Aya [1 ]
Naderpoor, Negar [1 ]
Mellett, Natalie [2 ]
Wilson, Kirsty [3 ]
Plebanski, Magdalena [3 ,4 ]
Meikle, Peter J. [2 ]
de Courten, Barbora [1 ]
机构
[1] Monash Univ, MCHRI, Sch Publ Hlth & Prevent Med, 43-51 Kanooka Grove, Clayton, Vic 3168, Australia
[2] Baker Heart & Diabet Inst, Metabol Lab, 75 Commercial Rd, Melbourne, Vic 3004, Australia
[3] Monash Univ, Dept Immunol & Pathol, 89 Commercial Rd, Melbourne, Vic 3004, Australia
[4] RMIT Univ, Sch Hlth & Biomed Sci, Corner Janefield Dr & Plenty Rd, Bundoora, Vic 3083, Australia
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2019年 / 1864卷 / 03期
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Lipid metabolism; Lipidomics; Diabetes; Insulin secretion; Metabolic dysfunction; Obesity; SKELETAL-MUSCLE; INSULIN-RESISTANCE; PLASMA CERAMIDES; POTENTIAL ROLE; LYSOPHOSPHATIDYLINOSITOL; ACID; PHOSPHATIDYLETHANOLAMINE; MITOCHONDRIA; HOMEOSTASIS; DEFICIENCY;
D O I
10.1016/j.bbalip.2018.12.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Advances in mass spectrometry and lipidomics techniques are providing new insights into the role of lipid metabolism in obesity-related diseases. However, human lipidomic studies have been inconsistent, owing to the use of indirect proxy measures of metabolic outcomes and relatively limited coverage of the lipidome. Here, we employed comprehensive lipid profiling and gold-standard metabolic measures to test the hypothesis that distinct lipid signatures in obesity may signify early stages of pathogenesis toward type 2 diabetes. Methods: Using high-performance liquid chromatography-electrospray tandem mass spectrometry, we profiled > 450 lipid species across 26 classes in 65 overweight or obese non-diabetic individuals. Intensive metabolic testing was conducted using direct gold-standard measures of adiposity (% body fat by dual X-ray absorptiometry), insulin sensitivity (hyperinsulinaemic-euglycaemic clamps), and insulin secretion (intravenous glucose tolerance tests), as well as measurement of serum inflammatory cytokines and adipokines (multiplex assays; flow cytometry). Univariable and multivariable linear regression models were computed using Matlab R2011a, and all analyses were corrected for multiple testing using the Benjamini-Hochberg method. Results: We present new evidence showing a strong and independent positive correlation between the lysophosphatidylinositol (LPI) lipid class and insulin secretion in vivo in humans (beta [95% CI] = 781.9 [353.3, 1210.4], p = 0.01), supporting the insulinotropic effects of LPI demonstrated in mouse islets. Dihydroceramide, a sphingolipid precursor, was independently and negatively correlated with insulin sensitivity (13 [95% CI] = -1.9 [ - 2.9, - 0.9], p = 0.01), indicating a possible upregulation in sphingolipid synthesis in obese individuals. These associations remained significant in multivariable models adjusted for age, sex, and % body fat. The dihexosylceramide class correlated positively with interleukin-10 before and after adjustment for age, sex, and % body fat (p = 0.02), while the phosphatidylethanolamine class and its vinyl ether-linked (plasmalogen) derivatives correlated negatively with % body fat in both univariable and age- and sex-adjusted models (all p < 0.04). Conclusions: Our data suggest that these lipid classes may signify early pathogenesis toward type 2 diabetes and could serve as novel therapeutic targets or biomarkers for diabetes prevention.
引用
收藏
页码:335 / 343
页数:9
相关论文
共 50 条
  • [21] Impact of weight loss after treatment on survival outcomes of overweight and obese patients with early-stage endometrial cancer
    Santana, Beatriz Navarro
    Soriano, Jose Verdu
    Arencibia, Octavio
    Petousis, Stamatios
    Margioula-Siarkou, Chrysoula
    Gonzalez, Daniel
    Laseca, Maria
    Rave, Andres
    Martinez, Alicia Martin
    ONCOLOGY LETTERS, 2024, 27 (02)
  • [22] Sodium Restriction Reveals Early Aortic Impedance and Left Ventricular (LV) Systolic Dysfunction in Overweight/Obese Hypertensives
    Shafiq, Qaiser
    Mitchell, Gary F.
    Solomon, Scott D.
    Williams, Jonathan S.
    CIRCULATION, 2013, 128 (22)
  • [23] Chronic Intermittent Hypoxia Induces Early-Stage Metabolic Dysfunction Independently of Adipose Tissue Deregulation
    Martins, Fatima O.
    Sacramento, Joana F.
    Olea, Elena
    Melo, Bernardete F.
    Prieto-Lloret, Jesus
    Obeso, Ana
    Rocher, Asuncion
    Matafome, Paulo
    Monteiro, Emilia C.
    Conde, Silvia, V
    ANTIOXIDANTS, 2021, 10 (08)
  • [24] Protein glycation ? biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
    Rabbani, Naila
    Thornalley, Paul J.
    REDOX BIOLOGY, 2021, 42
  • [25] Absolute quantitative lipidomics reveals lipids profiling in liver of mice with early-stage alcoholic liver disease
    Zhao, Fei
    Chen, Jun
    Guo, Rui
    Zhu, Jinyan
    Gu, Weijia
    Li, Songtao
    Li, Jiaomei
    NUTRITION & METABOLISM, 2022, 19 (01)
  • [26] Serum autoantibodies profiling and early-stage cancer detection
    Desmetz, Caroline
    Lacombe, Jerome
    Mange, Alain
    Maudelonde, Thierry
    Solassol, Jerome
    M S-MEDECINE SCIENCES, 2011, 27 (6-7): : 633 - 638
  • [27] Absolute quantitative lipidomics reveals lipids profiling in liver of mice with early-stage alcoholic liver disease
    Fei Zhao
    Jun Chen
    Rui Guo
    Jinyan Zhu
    Weijia Gu
    Songtao Li
    Jiaomei Li
    Nutrition & Metabolism, 19
  • [28] Transcriptome profiling and metabolic pathway analysis towards reliable biomarker discovery in early-stage lung cancer
    Thirunavukkarasu, Muthu Kumar
    Ramesh, Priyanka
    Karuppasamy, Ramanathan
    Veerappapillai, Shanthi
    JOURNAL OF APPLIED GENETICS, 2025, 66 (01) : 115 - 126
  • [29] Serum untargeted lipidomic profiling reveals dysfunction of phospholipid metabolism in subclinical coronary artery disease
    Djekic, Demir
    Pinto, Rui
    Repsilber, Dirk
    Hyotylainen, Tuulia
    Henein, Michael
    VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 : 123 - 135
  • [30] Early-stage face processing dysfunction in patients with schizophrenia
    Herrmann, MJ
    Ellgring, H
    Fallgatter, AJ
    AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (05): : 915 - 917